Drug Profile
Paclitaxel-eluting balloon catheter - Eurocor/Biosensors International Group
Alternative Names: BioPath 014; BioPath 035; BioStream; FREEWAY; FREEWAY 014; Freeway 014 paclitaxel releasing balloon catheter; FREEWAY 035; Freeway 035 paclitaxel releasing balloon catheter; Freeway paclitaxel balloon catheterLatest Information Update: 15 Jan 2022
Price :
$50
*
At a glance
- Originator Eurocor
- Class Antineoplastics; Diterpenes; Paclitaxels; Skin disorder therapies; Small molecules; Taxanes; Vascular disorder therapies
- Mechanism of Action Mitosis inhibitors; Platelet-derived growth factor inhibitors; Tubulin inhibitors; Tubulin polymerisation promoters
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Peripheral arterial occlusive disorders
Most Recent Events
- 29 Sep 2021 Discontinued - Phase-III for Peripheral arterial occlusive disorders in Hungary, Austria, Spain, Italy, Germany (Intra-arterial)
- 01 May 2011 Phase-III clinical trials in Peripheral arterial occlusive disorders in Colombia, Germany, Italy, Spain and Austria (Intra-arterial) (NCT01960647)